BioSpace News Archive

Junshi Biosciences announced that an Independent Monitoring Committee determined that the randomized, double-blind, placebo-controlled, international multi-center Phase III study JUPITER-02 at the interim analysis had met its pre-specified primary endpoint.

Quidel Corporation (NASDAQ: QDEL) (“Quidel”), a provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, issued the following statement supporting the Administration’s plans to provide COVID-19 rapid tests to school children. “Quidel Corporation welcomes President Trump’s announcement that the Administration will direct millions of Abbott’s visually read antigen t

Aziyo Biologics, Inc. (“Aziyo”), a commercial-stage regenerative medicine company focused on creating the next generation of differentiated products and improving outcomes in patients undergoing surgery, announced today that Matthew Ferguson has been appointed Chief Financial Officer (CFO), effective immediately. “We are extremely pleased to welcome a strong leader like Matt to the Aziyo team at such an important point in our business’ g

Varex Imaging Corporation (Nasdaq: VREX) today announced it has priced a private offering (the “Offering”) of $300 million aggregate principal amount of 7.875% senior secured notes due 2027 (the “notes”) at an offering price of 100% of the principal amount thereof

Sangamo Therapeutics, Inc., a genomic medicine company, announced that management will present at the following investor conferences

Cerus Corporation (Nasdaq:CERS) announced today its lineup of abstract presentations at the AABB 2020 Virtual Annual Meeting, which will take place on October 3rd through October 5th.

Jaguar Health, Inc. (NASDAQ:JAGX) announced today that the company’s wholly owned subsidiary, Napo Pharmaceuticals, Inc. (Napo), is a proud sponsor of this year’s National Trans Visibility March (NTVM), a week-long virtual event beginning September 28, 2020.

Covetrus, a global animal-health technology and services company, announced the agenda and speaker lineup for its annual VetSummit conference that is to take place October 16-18.

Innovent Biologics, Inc., a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncology, metabolic, autoimmune and other major diseases, announces that it will host an online virtual R&D day to mainly discuss the Company’s pipeline and research.

PTC Therapeutics, Inc. announced that two-year data from Part 1 of the FIREFISH study demonstrated that infants on Evrysdi™ continued to improve and achieve motor milestones.